NIH Nominee Discusses Vaccine Skepticism, Research Funding, and NIH Reform

NIH Research Funding and Indirect Costs

• 💡 The current cap on indirect fees for NIH grants has been traumatic to the system, necessitating a more transparent and fair system for research centers across the country.
• 🎯 Transparency through audits of university spending on indirect costs is crucial for informed decision-making regarding research funding.
• 🔑 If confirmed as NIH director, the nominee pledges to carefully examine the issue of indirect cost caps and the broader problem of deep public distrust in the scientific establishment.

Cross-Institute Collaboration and Research

• 🚀 The nominee expresses enthusiasm for working on the DeAndre Dixon Inclusion Project Act, which aims to codify research activities at NIH on co-occurring disorders of Down syndrome.
• 🧩 There are tremendous opportunities for cross-disciplinary work across NIH institutes to unlock new discoveries and prevent research from remaining siloed.

US Leadership in Global Research

• 🔬 The United States leads the world in fundamental research, with 99% of FDA-approved drugs developed with NIH research to some extent.
• ✅ The nominee views this global leadership not as being "ripped off" but as a benefit to all humanity, as NIH research is fundamentally aimed at the public good.

Challenges in the Scientific Establishment

• ⚠️ Concerns are raised about the replicability crisis, a lack of focus on diseases afflicting Americans, and tentativeness in pursuing big ideas within the scientific establishment.
• 📈 The nominee aims to reform NIH research to address these issues and is open to working with Congress on budget decisions.

Addressing Vaccine Skepticism

• ⚠️ Rising vaccine skepticism, viewed as a hangover from the COVID-19 pandemic, makes vaccine research at NIH even more important.
• 💬 The nominee believes that rigorously conducted and replicable research is persuasive and will ultimately encourage people to take appropriate actions, including vaccination.